Next Article in Journal
Compassionate Use Program of Ipilimumab and Nivolumab in Intermediate or Poor Risk Metastatic Renal Cell Carcinoma: A Large Multicenter Italian Study
Previous Article in Journal
Hypoxia as a Modulator of Inflammation and Immune Response in Cancer
Previous Article in Special Issue
Cell Type-Specific Roles of STAT3 Signaling in the Pathogenesis and Progression of K-ras Mutant Lung Adenocarcinoma
 
 
Article

Article Versions Notes

Cancers 2022, 14(9), 2292; https://doi.org/10.3390/cancers14092292
Action Date Notes Link
article xml file uploaded 4 May 2022 11:58 CEST Original file -
article xml uploaded. 4 May 2022 11:58 CEST Update -
article pdf uploaded. 4 May 2022 11:58 CEST Version of Record https://www.mdpi.com/2072-6694/14/9/2292/pdf-vor
article supplementary file uploaded. 4 May 2022 11:58 CEST - https://www.mdpi.com/2072-6694/14/9/2292#supplementary
article html file updated 4 May 2022 11:59 CEST Original file -
article xml file uploaded 6 May 2022 04:17 CEST Update -
article xml uploaded. 6 May 2022 04:17 CEST Update https://www.mdpi.com/2072-6694/14/9/2292/xml
article pdf uploaded. 6 May 2022 04:17 CEST Updated version of record https://www.mdpi.com/2072-6694/14/9/2292/pdf
article html file updated 6 May 2022 04:19 CEST Update -
article supplementary file uploaded. 6 May 2022 04:25 CEST - https://www.mdpi.com/2072-6694/14/9/2292#supplementary
article html file updated 6 May 2022 04:25 CEST Update -
article html file updated 12 May 2022 10:58 CEST Update -
article html file updated 2 August 2022 22:09 CEST Update https://www.mdpi.com/2072-6694/14/9/2292/html
Back to TopTop